Lista de obras -

5q21 deletion is often heterogeneous in prostate cancer

scientific article published on 24 January 2019

8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival

artículo científico publicado en 2019

A non-diploid DNA status is linked to poor prognosis in renal cell cancer

scientific article published on 02 May 2020

Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma

scientific article published on 12 October 2018

Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrence

artículo científico publicado en 2015

Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

scientific article published in Scientific Reports

Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

artículo científico publicado en 2017

Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer

artículo científico publicado en 2015

Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer

scientific article published on 02 November 2015

Deletion of 18q is a strong and independent prognostic feature in prostate cancer

artículo científico publicado en 2016

Deletion of 8p is an independent prognostic parameter in prostate cancer

artículo científico publicado en 2016

Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion

artículo científico publicado en 2015

Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphoma

artículo científico publicado en 2018

Expression of the immune checkpoint receptor TIGIT in seminoma

scientific article published on 31 May 2019

FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy

artículo científico publicado en 2017

Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer

artículo científico publicado en 2017

Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

artículo científico publicado en 2015

HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer

artículo científico publicado en 2015

Heterogeneity in D'Amico classification-based low-risk prostate cancer: Differences in upgrading and upstaging according to active surveillance eligibility

artículo científico publicado en 2015

Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients.

artículo científico publicado en 2016

High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

artículo científico publicado en 2018

High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases

High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer

artículo científico publicado en 2010

High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer.

artículo científico publicado en 2017

High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer

artículo científico publicado en 2015

High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer

artículo científico publicado en 2017

Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder

artículo científico publicado en 2019

Immunohistochemically detected IDH1R132H mutation is rare and mostly heterogeneous in prostate cancer

artículo científico publicado en 2018

Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer

artículo científico publicado en 2017

Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.

artículo científico publicado en 2017

Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers

artículo científico publicado en 2015

Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancers

artículo científico publicado en 2020

Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer

artículo científico publicado en 2018

Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters

artículo científico publicado en 2015

Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers

artículo científico publicado en 2017

Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer

artículo científico publicado en 2015

Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer

artículo científico publicado en 2019

Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers

artículo científico publicado en 2015

Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancers

artículo científico publicado en 2014

TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer

artículo científico publicado en 2014

The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate Cancer

artículo científico publicado en 2016

The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion

artículo científico publicado en 2015

Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

artículo científico publicado en 2017

Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer

artículo científico publicado en 2017

Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer

artículo científico publicado en 2016

VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy

artículo científico publicado en 2015

Lista de obras de

5q21 deletion is often heterogeneous in prostate cancer

8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival

A non-diploid DNA status is linked to poor prognosis in renal cell cancer

Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma

Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrence

Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer

Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer

Deletion of 18q is a strong and independent prognostic feature in prostate cancer

Deletion of 8p is an independent prognostic parameter in prostate cancer

Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion

Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphoma

Expression of the immune checkpoint receptor TIGIT in seminoma

FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy

Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer

Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer

Heterogeneity in D'Amico classification-based low-risk prostate cancer: Differences in upgrading and upstaging according to active surveillance eligibility

Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients.

High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases

High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer

High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer.

High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer

High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer

Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder

Immunohistochemically detected IDH1R132H mutation is rare and mostly heterogeneous in prostate cancer

Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer

Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.

Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers

Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancers

Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer

Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters

Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers

Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer

Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer

Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers

Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancers

TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer

The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate Cancer

The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion

Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer

Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer

VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy